A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer
Clinical trial NCT04398940 · UNKNOWN
Trial details
- NCT number
- NCT04398940
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2022-01-31
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.